Balyasny Asset Management »

Larimar Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $926k 287k 3.23
2024-12-31 $308k 80k 3.87

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Blue Owl Capital Holdings
Millennium Management
Opaleye Management
BlackRock
Rtw Investments
Vanguard Group
Caption Management
Logos Global Management
Adage Capital Partners GP
Alyeska Investment Group
Citadel Advisors
Woodline Partners
Goldman Sachs Group

View all funds holding Larimar Therapeutics